ResMed

Owners of ResMed (NYSE: RMD) shares as of market close today will be eligible for a dividend of 25 cents per share. At a price of $49.50 as of 9:35 a.m. ET, the dividend yield is 2%.

The average volume for ResMed has been 1.1 million shares per day over the past 30 days. ResMed has a market cap of $7.0 billion and is part of the health services industry. Shares are up 17.2% year to date as of the close of trading on Wednesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company has a P/E ratio of 23.41.

TheStreet Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full ResMed Ratings Report now.

If you liked this article you might like

TDK Snaps Up Apple Supplier InvenSense for $1.3 Billion

Apple Supplier Infineon Expected to Report 12% Revenue Growth

This Chipmaker Could Benefit Significantly From a Trump Presidency

Now That Qualcomm Has Dealt for NXP, Here's Who Else Might Get Snatched Up

Qualcomm's $47 Billion Mega-Deal for NXP: Where It Stacks Up in History